ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lonza, Forbion and BioGeneration Ventures Extend Collaboration
January 18, 2022To add development and manufacturing services of small molecules. -
Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (US
March 19, 2018Forbion, today announces that H. Lundbeck A/S (Lundbeck) has acquired Forbion’s portfolio company Prexton Therapeutics B.V. (Prexton) for a total consideration of EUR 905 million (USD 1.1 billion). -
Forbion Leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Syst
March 14, 2018Forbion, today announced that it led the $19 million Series B financing of Escalier Biosciences BV, a privately held biopharmaceutical company based in Nijmegen, The Netherlands.
Pharma Sources Insight January 2025
